At EASD Obesity Week, on 17 September, Dr Lee Kaplan presented findings from a multi-organ MRI study, co-authored with Perspectum, showing how advanced imaging biomarkers can predict health benefits from anti-obesity pharmacotherapy.
The talk emphasised the role of non-invasive imaging in assessing treatment response and advancing obesity care.